LLY241108C897500
- 0.24
- -0.57-70.37%
Eli Lilly and Co Newsroom
Direct hit on the USA election: When is the earliest possible outcome of this election?
The earliest time the results of this year's usa election will be announced. Market volatility is likely to soar, traders need to do risk management.
Direct hit on the USA election | Trump vs. Harris, who will win?
The 2024 US presidential election will officially vote on November 5, kicking off a critical battle that will determine the future direction of the United States.
Barclays Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $975
【Real-time Tracking】Trump vs. Harris, who will ultimately take over the White House?
On November 5th, USA will hold the 60th presidential election, the current vice president Harris and former president Trump will officially compete. Finance Associated Press will track and report the latest developments of this election, so please stay tuned.
Viking Therapeutics (VKTX.US) weight loss drug emerging unexpectedly, challenging the traditional leaders in the field.
The data released earlier on Monday by viking therapeutics on the weight-loss drug VK2735 indicates that novo-nordisk a/s and eli lilly and co, currently dominating the obesity drug market, may face fierce competition in the future.
Futu Morning Post | Countdown to the election! The panic index VIX is burning high and uncertainty is haunting the market nerves; Up nearly 13% after hours! Palantir raises full-year revenue guidance
Jpmorgan warns: If Trump wins on Wednesday, the Fed may pause the easing cycle as early as December; Will the US stock market hit new highs after the election? Jpmorgan: FOMO psychology boosts, S&P may hit 6100 points by the end of the year; US polls: Harris and Trump are neck and neck in key 'swing states'.
Is Eli Lilly and Company (LLY) the Best Pharma Stock to Buy Right Now?
US stocks closed: Trump, Harris concept stocks rose together, Chinese concept stocks remained stable and rose.
1. The market is filled with a wait-and-see attitude, with all three major indexes collectively falling. 2. Trump's media technology group rebounded after hitting bottom. 3. Photovoltaic and clean energy concept stocks strengthened collectively. 4. Reports claim that Nvidia will distribute Super Micro Computer orders to other suppliers.
Viking Stock Drops 13% After Jumping 9% on Obesity Drug Data
Eli Lilly (NYSE:LLY) Stock Falls as Competitors Report Progress
Deutsche Bank Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $1,015
Eczema Drug Developer Nektar Gains Analyst Confidence With 400% Upside Potential
Eli Lilly Is Maintained at Buy by Deutsche Bank
Express News | Refile-Weight-Loss Drugmaker Eli Lilly's Shares Fall 1% (Refiles to Add Metadata)
New weight loss drug CagriSema planned to be launched by novo-nordisk a/s is expected to alleviate the problem of rebound after discontinuation, with a minimum weight loss of 25%!
CagriSema combines the two ingredients of semaglutide and pancreatic amylase, is expected to achieve the best efficacy in history with a 25% weight loss, compared to the previous generation of weight loss drug Wegovy, it will not bring additional side effects, and is expected to alleviate gastrointestinal side effects such as nausea and vomiting.
Eli Lilly (LLY) Stock Price Prediction and Forecast 2025-2030
USA election, who will win? The two main candidates are battling in the 'swing states', this guide for watching and trading is worth collecting!
This may determine the direction of the US economy for the next four years. This may determine the direction of the US economy for the next four years.
Big Pharma's Obesity Bonanza Faces New Tests -- Heard on the Street -- WSJ
Redburn Atlantic Adjusts Price Target on Eli Lilly to $700 From $640, Maintains Neutral Rating
This Pharma Stock Is Soaring 21%. The Weight-Loss Drugs Race Has Widened Beyond Lilly, Novo. -- Barrons.com